⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Global Protein Expression Market to Reach USD 7.30 Billion by 2034 at 8.8% CAGR as Rising Biopharmaceutical Development, Growing Demand for Recombinant Proteins, and Advances in Cell-Free Expression Technologies Accelerate Market Growth, Reports Maximize
prnewswire.com
TMO
AMGN
AGNC
BIO
QGEN
BIIB
GILD
REGN
BMY
MRK
SNY
LLY
ABBV
PFE
JNJ
AZN
BSX
MDLZ
GEHC
SYK
EW
ISRG
GOOG
MSFT
NVDA
AMAT
KLAC
LRCX
INTC
AMD
MU
WDC
SE
CRM
IBM
ORCL
SAP
ACN
GEN
PRG
EXAS
DXCM
ALGN
IDXX
VRTX
XRAY
CTAS
MDT
AMZN
GOOGL
CTSH
INFY
HPE
DELL
HPQ
LOGI
ADBE
CDNS
SNPS
MRVL
QCOM
NXPI
ON
ADI
TXN
MCHP
QRVO
NTAP
STX
WD
CRWD
PANW
FTNT
DDOG
SNOW
ETSY
ROKU
PYPL
MELI
JD
BABA
NTES
PDD
IQ
VIPS
NIO
LI
XPEV
RIVN
TSLA
GM
F
STLA
TM
VWAGY
HOG
Alzheimer's Disease Competitive Landscape and Clinical Trial Analysis Report 2026: More Than 200 Companies and 240 Therapies Assessed
globenewswire.com
LLY
BIIB
JNJ
SNY
ALNY
ABBV
BMY
REGN
XCUR
Global Lupus Nephritis Market to Reach USD 4.08 Billion by 2034 at 8.5% CAGR as Rising Disease Burden and Breakthroughs in Targeted Therapies Accelerate Market Expansion, Says Maximize Market Research
prnewswire.com
PFE
AZN
MRK
BMY
GSK
AMGN
BIIB
JNJ
VRTX
IMVT
ABBV
LLY
SNY
REGN
GILD
BHC
AUR
UCB
An Open Letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi
globenewswire.com
AZN
BMY
GSK
NVO
NVS
ROG
SNY
Capitalize on the Orphan Drug Revenue Shift: Benchmark Novartis, Roche, Pfizer, Sanofi and AstraZeneca to Secure High-Value Growth Before Rivals Move First
globenewswire.com
NVS
PFE
SNY
AZN
ZERO Prostate Cancer Concludes Fifth Annual Support Group Leader & MENtor Training with Record Engagement and Expert-Led Learning
prnewswire.com
PFE
NVS
AZN
SNY
S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
prnewswire.com
LLY
JNJ
SNY
ZLAB
Trialynx Wins Forge’s DPHARM Idol Disrupt 2026
globenewswire.com
NVS
SNY
PFE
JNJ
Viral Vector Collaboration and Licensing Deals 2016-2026 Report Examines 450+ Transactions, Deal Structures and Market Trends
globenewswire.com
AZN
BIIB
BMY
LLY
GILD
JNJ
NVS
PFE
SNY
TMO
VRTX
GLP-1 Therapies Market Set for Rapid Growth Through 2034 as Obesity and Diabetes Demand, Drug Innovation, and Expanding Indications Fuel New Business Opportunities
globenewswire.com
NVO
LLY
AZN
SNY
GSK